EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased ADORA1 expression in pancreatic islets coincides with insulin secretory defects in human type 2 diabetes

Israa Mohammed Al-Amily, Fariborz Parandeh, Stefan Amisten, Pontus Dunér, Sandra Meidute-Abaraviciene, Eva Grapengiesser, Bo Hellman, Albert Salehi

Journal of Biological Chemistry · 2026-10 · 302 (10) · 113501

DOI: 10.1016/j.jbc.2026.113501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-10. Verfasst von Israa Mohammed Al-Amily und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, Malmö, Division of Islet Cell Physiology, University of Lund, Lund, Sweden. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Islets of Langerhans, Insulin, Receptor, Adenosine A1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mats Paulssons Stiftelse, Vetenskapsrådet, Diabetesförbundet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenosine receptors (ADORAs) are G-protein coupled receptors that critically modulate cell function, yet their specific roles in regulating insulin and glucagon secretion remain incompletely understood. While RNA sequencing of isolated human islets, confirmed by qPCR, revealed that only ADORA1 and ADORA2A transcripts are abundantly expressed, mouse islets express all four receptor subtypes (Adora1, Adora2a, Adora2b, and Adora3). Confocal immunofluorescence demonstrated ADORA1 protein localization in both islet β- and α-cells. Transcriptome correlation analysis of human islets identified 87 genes strongly associated with ADORA1 expression, enriched in pathways regulating carbohydrate and lipid metabolism, cell cycle, apoptosis, proliferation, endocrine system development, and metabolic disease. ADORA1 mRNA levels were positively correlated with HbA1c and elevated in islets of type 2 diabetes (T2D) donors, implicating ADORA1 in β-cell dysfunction. In ob/ob mouse islets, reduced Adora1 expression coincided with enhanced pulsatile insulin secretion, while the control islets showed a biphasic with a weaker second phase insulin secretory response. Adenosine efficiently suppressed insulin secretion in both ob/ob and control islets. ADORA1 antagonist DPCPX attenuated adenosine-induced suppression of insulin release. Adora1-KD mice exhibited a restored, pulsatile second-phase insulin response absent in controls. In human islets, adenosine suppressed both glucose-stimulated insulin secretion and cAMP generation, effects prevented by DPCPX. Adenosine also impaired β-cell viability and proliferation, which were rescued by ADORA1 inhibition. Collectively, our findings identify ADORA1 as a key inhibitory modulator of β-cell function under diabetogenic stress, thereby a promising therapeutic target to preserve insulin secretory capacity in early T2D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Islets of LangerhansInsulinReceptor, Adenosine A1HumansAnimalsMiceInsulin SecretionMaleMice, Inbred C57BL

Stichwörter der Autor:innen

G-protein coupled receptorsGPCRscAMP/PKA systemgene expressionmetabolic diseases

Substanzen

InsulinReceptor, Adenosine A1

Autor:innen und Institutionen

  • Department of Clinical Science, Malmö, Division of Islet Cell Physiology, University of Lund, Lund, Sweden.
  • Experimental Cardiovascular Research, University of Lund, Lund, Sweden.
  • Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Department of Clinical Science, Malmö, Division of Islet Cell Physiology, University of Lund, Lund, Sweden. Electronic address: S_Albert.Salehi@med.lu.se.

Förderung

  • Mats Paulssons Stiftelse
  • Vetenskapsrådet
  • Diabetesförbundet
  • Novo Nordisk Fonden
  • Lunds Universitet

Zitieren

APA

Mohammed Al-Amily, I., Parandeh, F., Amisten, S., Dunér, P., Meidute-Abaraviciene, S., Grapengiesser, E., Hellman, B., & Salehi, A. (2026). Increased ADORA1 expression in pancreatic islets coincides with insulin secretory defects in human type 2 diabetes. Journal of Biological Chemistry, 302(10), 113501. https://doi.org/10.1016/j.jbc.2026.113501

Vancouver

Mohammed Al-Amily I, Parandeh F, Amisten S, Dunér P, Meidute-Abaraviciene S, Grapengiesser E, et al. Increased ADORA1 expression in pancreatic islets coincides with insulin secretory defects in human type 2 diabetes. Journal of Biological Chemistry. 2026;302(10):113501. doi:10.1016/j.jbc.2026.113501

BibTeX
@article{MohammedAlAmily2026,
  author = {Mohammed Al-Amily, Israa and Parandeh, Fariborz and Amisten, Stefan and Dunér, Pontus and Meidute-Abaraviciene, Sandra and Grapengiesser, Eva and Hellman, Bo and Salehi, Albert},
  title = {Increased ADORA1 expression in pancreatic islets coincides with insulin secretory defects in human type 2 diabetes},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  volume = {302},
  number = {10},
  pages = {113501},
  doi = {10.1016/j.jbc.2026.113501}
}
Kostenlos starten →